Navigation Links
Sihuan Pharmaceutical Announces 2011 Annual Results
Date:3/19/2012

ne-third of our total sales.

The Company's non-CCV products, such as Zhuo'ao, Bi'ao, Ren'ao and Pojia also recorded satisfactory performance in 2011, which is mainly attributable to stronger sales and marketing capabilities and successful tendering. Sales of these products increased 7.6% to RMB212.1 million, representing approximately 9.5% of total revenue. Sales of its key product, Ren'Ao, Zhuo'Ao and Bi'Ao, Pojia and Luoanming posted satisfactory growth. Among the Company's non-CCV products, anti-infective drugs have seen decreases in sales, mainly due to government regulations on the clinical usage of anti-infectives.

Outlook for 2012Looking forward, the Company will continue to optimize its product portfolio and enhance its sales and marketing capabilities to take advantage of broader market opportunities. In particular, the Company will focus on maintaining a steady growth of its existing products, supporting fast-growing newly acquired products, and improving the range and market share of CCV products to solidify its leading position in China's CCV prescription drug market. For its non-CCV products, the Company will explore other therapeutic areas such as oncology and CNS.  The Company will also continue to strengthen its proven sales and marketing model to further its penetration in the country to maximize the delivery of its existing and newly acquired products and drive overall performance.

Sihuan Pharmaceutical will identify appropriate opportunities for acquisition and collaboration that complement its business development strategies. The Company has also placed equal importance on R&D during the current year and is looking to expand its efforts beyond pharmaceuticals and into high-growth potential areas such as biotechnology. The Company is actively seeking opportunities for cooperation with overseas pharmaceutical companies in joint ventures and innovation initiatives to optimize its product portfolio and support the ex
'/>"/>

SOURCE Sihuan Pharmaceutical Holdings Group Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sihuan Pharmaceutical Achieves Important R&D Breakthrough
2. Branded Prescription Pharmaceutical Sales Outlook to 2016
3. Pharmaceuticals: Global Industry Guide
4. Avanir Pharmaceuticals Announces Appointment of Rohan Palekar as Chief Commercial Officer
5. JacksonWhite Files Overtime Lawsuit Against Sunovion Pharmaceuticals
6. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Financial Results and Reviews Recent Developments
7. Pharmaceutical & Healthcare Annual Deals Analysis 2012
8. Omnicell to Exhibit at Dubai International Pharmaceuticals and Technologies Conference and Exhibition
9. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Wednesday, March 14
10. Auxilium Pharmaceuticals to Present at the 2012 Barclays Capital Global Healthcare Conference
11. S1 Pharmaceuticals Announces New Executive Management and Scientific Advisory Board Appointments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Feb. 27, 2015  Finesse expands office in ... announced the expansion of its operations in ... mid-March and access for customers is expected shortly afterward. ... located adjacent to the current office, the new premises ... team and allow Finesse to bring on more service ...
(Date:2/26/2015)...  IRIDEX Corporation (NASDAQ: IRIX ) today announced ... 2014 financial results after the market closes on Thursday, ... Company will host a conference call with the investment community ... March 5, 2015 to discuss the results of the ... access the live conference call via telephone by dialing (877) ...
(Date:2/26/2015)... 26, 2015 LifeScienceIndustryResearch.com adds ... -In- Class Innovations and Cost Optimization Plays Major ... Pharmaceutical Companies research report to the pharmaceuticals intelligence ... this Global Pharma US & EU Outlook 2015 ... divestment of non-core assets result in healthy cash ...
Breaking Medicine Technology:New Finesse Office in United Kingdom 2IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2Global Pharma U.S. and EU Outlook 2015 Market Research Report 2Global Pharma U.S. and EU Outlook 2015 Market Research Report 3Global Pharma U.S. and EU Outlook 2015 Market Research Report 4
... Oct. 18 Innovation is the key to ... However, not only must companies produce superior products, ... entire lifecycle to achieve success. This includes everything ... Strategic partners specializing in lifecycle management can provide ...
... THOUSAND OAKS, Calif., Oct. 18 Amgen (Nasdaq: ... (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy) ... use of erythropoiesis-stimulating agents (ESAs) for chronic renal failure ... Drug Administration,s (FDA) Cardiovascular and Renal Drugs Advisory Committee ...
Cached Medicine Technology:Frost & Sullivan: Strategic Partnerships Crucial to Medical Device Success 2Frost & Sullivan: Strategic Partnerships Crucial to Medical Device Success 3Amgen to Review Results From TREAT and Propose Updates to ESA Labeling for Chronic Renal Failure Patients at an FDA Advisory Committee Meeting Today 2Amgen to Review Results From TREAT and Propose Updates to ESA Labeling for Chronic Renal Failure Patients at an FDA Advisory Committee Meeting Today 3Amgen to Review Results From TREAT and Propose Updates to ESA Labeling for Chronic Renal Failure Patients at an FDA Advisory Committee Meeting Today 4Amgen to Review Results From TREAT and Propose Updates to ESA Labeling for Chronic Renal Failure Patients at an FDA Advisory Committee Meeting Today 5Amgen to Review Results From TREAT and Propose Updates to ESA Labeling for Chronic Renal Failure Patients at an FDA Advisory Committee Meeting Today 6Amgen to Review Results From TREAT and Propose Updates to ESA Labeling for Chronic Renal Failure Patients at an FDA Advisory Committee Meeting Today 7Amgen to Review Results From TREAT and Propose Updates to ESA Labeling for Chronic Renal Failure Patients at an FDA Advisory Committee Meeting Today 8
(Date:2/28/2015)... A study out of the University of ... for the treatment of a hereditary ocular condition that ... by Dr. Robert MacLaren, professor of ophthalmology at the ... Journal on January 16, 2014 , the study treated ... that mostly affects men and leads to the degeneration ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 Dr. ... Central Coast area residents, recently announced a special offer ... It’s a treatment option for new and established patients ... 2015 with a bright, white smile, Dr. Patel and ... of $299, marked down from the regular price of ...
(Date:2/28/2015)... On Thursday, February 26th, Forbes published an article ... To Steal Your Data , which stresses the ease with ... DIY phishing kit, or any kind of malware kit for ... point about how everyone’s cyber security is intertwined when it ... legitimate content management systems or blogs in order to install ...
(Date:2/28/2015)... “ Powermod ” was featured on NewsWatch as ... at the latest and coolest technology products and services available ... a technology expert, conducted the review and shared with viewers ... Getting stuck with a low battery and no way to ... face on a daily basis. Even when a person does ...
(Date:2/28/2015)... February 28, 2015 1Heart Caregiver ... showcased emerging brand at Houston Texas Franchise Expo ... Vegas sending its executive delegates headed by Vice-President ... Development and Training Randolph Clarito. , Franchise Expo ... held last February 4-7 and featured Franchise brands ...
Breaking Medicine News(10 mins):Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2Health News:Pismo Beach Dentist Announces Special for Zoom! Teeth Whitening 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4Health News:Solutions to Keep Phones Charged were Featured on NewsWatch Television on January 29, 2015 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 3
... Rx Bottles Filled with Constituent Health Care Stories Send Strong ... to Washington , , DECATUR, ... to Washington D.C. after their summer break, Decatur AARP members are ... top priority. With a giant inflatable Rx bottle as backdrop, and ...
... , SOMERSET, N.J., Sept. 8 ... of EDLUAR(TM) (zolpidem tartrate sublingual tablets) in the United ... insomnia characterized by difficulties with falling asleep. EDLUAR is ... is the most prescribed treatment for insomnia. Zolpidem tartrate ...
... CENTENNIAL, Colo., Sept. 8 Cochlear, the global ... U.S. Food and Drug Administration (FDA) has approved the ... hearing loss. Working with leading surgeons and audiologists worldwide, ... smaller and thinner device with an unparalleled capability to ...
... New York Football Giants are asking their fans to help save lives ... Sept. 8 We heard you bleed BLUE! Come out and ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090908/DC71650LOGO ) , , On Saturday, September 12, ... Red Cross to host a blood drive. The blood drive is ...
... 8 /PRNewswire-FirstCall/ - (OTCBB: GVBP.OB) - GENova Biotherapeutics, Inc., ... a patent for a novel peptide that disrupts the ... as a new anti-cancer drug. , The peptide, called ... to prostate cancer cells, and has the ability to ...
... 15 ESMO 34 will take place at the ... Berlin, Germany ( www.icc-berlin.de ) from Sunday 20 September ... more than 2,000 presentations and over 15,000 participants from ... to date. The congress will discuss the latest ...
Cached Medicine News:Health News:Meda Introduces EDLUAR(TM), the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication, Zolpidem Tartrate 2Health News:Meda Introduces EDLUAR(TM), the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication, Zolpidem Tartrate 3Health News:Meda Introduces EDLUAR(TM), the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication, Zolpidem Tartrate 4Health News:Cochlear Americas Announces FDA Approval of the Nucleus(R) 5 System, the Newest and Most Advanced Cochlear Implant System 2Health News:Cochlear Americas Announces FDA Approval of the Nucleus(R) 5 System, the Newest and Most Advanced Cochlear Implant System 3Health News:Cochlear Americas Announces FDA Approval of the Nucleus(R) 5 System, the Newest and Most Advanced Cochlear Implant System 4Health News:New York Giants to Host American Red Cross Blood Drive 2Health News:Genova files patent for new prostate cancer treatment 2Health News:Media registration for ECCO 15 -- ESMO 34 multidisciplinary cancer congress 2Health News:Media registration for ECCO 15 -- ESMO 34 multidisciplinary cancer congress 3
... Pipetman Ultra is a fully adjustable, ... display. It is the latest member of ... same characteristics: robustness, accuracy, and precision. We ... on feedback from our customers. Eight models ...
... Finnpipette Digital offers improved ergonomics for ... handle, modified grippy finger rest and ... comfort and efficiency. Finnpipette Digitals also ... gearing mechanism (pat. pend.) and super ...
... Finnpipette Techpette combines form and ... pipette. Advanced pipetting technology, plus ... quality, safety, comfort and accuracy. ... range is an important safety ...
... In the specialty areas of ... intensive care work, it is ... your practice. Alokas motorized TEE ... and Tissue Harmonic Echo technology ...
Medicine Products: